In this study, we successfully generated monoclonal antibodies against TM4SF4—a transmembrane protein overexpressed in lung cancer cells—through immunization of mice with a short antigenic peptide derived from its LEL domain. This evidence concerns the gene TM4SF4 and lung carcinoma.